Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Operating Expenses | 35,319 | 33,584 | 52,439 | 32,830 | 20,021 |
| Operating Income | -35,319 | -33,584 | -52,439 | -32,830 | -20,021 |
| Interest Expense | 1,256 | 1,272 | 1,295 | 1,286 | 1,262 |
| Other Income | 23 | 13 | 13 | 11 | 182 |
| Pre-tax Income | -36,552 | -34,843 | -53,721 | -34,105 | -21,101 |
| Net Income Continuous | -36,552 | -34,843 | -53,721 | -34,105 | -21,101 |
| Net Income | $-36,552 | $-34,843 | $-53,721 | $-34,105 | $-21,101 |
| EPS Basic Total Ops | -1.00 | -0.96 | -1.60 | -1.02 | -0.64 |
| EPS Basic Continuous Ops | -1.00 | -0.96 | -1.60 | -1.02 | -0.64 |
| EPS Diluted Total Ops | -1.00 | -0.96 | -1.60 | -1.02 | -0.64 |
| EPS Diluted Continuous Ops | -1.00 | -0.96 | -1.60 | -1.02 | -0.64 |
| EBITDA(a) | $-34,854 | $-33,095 | $-51,964 | $-32,382 | $-19,599 |